Topic: artificial intelligence

The Short Report, June 19, 2019 – Research chairs, cybersecurity, Strategic Innovation Fund

Science and Sports minister Kirsty Duncan has announced over $275 million for 346 new and renewed Canada Research Chairs at 52 institutions across Canada. It was the most gender diverse competition yet: 47% women, 22% visible minorities, 5% persons with disabilities, and 4% Indigenous peoples. The Canada Foundation for Innovation is contributing another $5.2 million…

The Short Report, June 5, 2019 – McMaster endowment, AI, timber research, green jet fuel

BDC Capital has launched the $250-million Industrial Innovation Venture Fund to invest in early to late stage tech firms and entrepreneurs accelerating the transformation of core Canadian industries including ag-tech, advanced manufacturing, oil and gas and mining tech. Venture capital veteran Joe Regan joins as the fund’s managing partner. “Industrial sectors tend to be slow…

Agrafioti and Bengio to chair new Advisory Council on AI

Innovation minister Navdeep Bains has launched the Advisory Council on Artificial Intelligence to advise government on how to build Canada’s AI strengths, create economic growth and ensure AI advancements reflect Canadian values such as human rights, transparency and openness. The new council will establish a working group on commercializing value from Canadian-owned AI and data…

The Short Report – May 15, 2019: Early career awards, cannabis R&D, AI

Minister of Science and Sport Kirsty Duncan has announced the first 157 early career researchers to share $38 million under the recently launched New Frontiers in Research Fund. Each recipient will receive up to $250,000 over the next two years to support international, interdisciplinary, fast-breaking and high-risk research. – Newswire Vancouver-based Centre for Drug Research…

The Short Report – May 8, 2019: Cannabis R&D, fuel cell demo, accelerator funding

With the goal becoming a mainstream healthcare company, Smiths Falls, ON-based Canopy Growth Corp. has spun off a new division – Spectrum Therapeutics – to oversee the company’s commercial medical and clinical research operations including Spectrum Cannabis, Canopy Health Innovations, and recently acquired Germany-based C3Cannabinoid Compound Company, which develops cannabinoid-based medical therapies. – Canopy Growth…